Left Menu
Development News Edition

Scientists identify two antibodies from llamas that can neutralise coronavirus

Scientists have demonstrated that two small, stable antibody variants derived from the South American mammals llamas can neutralise the novel coronavirus in lab-cultured cells, an advance which may lead to the development of new therapeutics against COVID-19.

PTI | London | Updated: 13-07-2020 17:37 IST | Created: 13-07-2020 17:24 IST
Scientists identify two antibodies from llamas that can neutralise coronavirus
Representative Image Image Credit: Videoblocks

Scientists have demonstrated that two small, stable antibody variants derived from the South American mammal's llamas can neutralize the novel coronavirus in lab-cultured cells, an advance that may lead to the development of new therapeutics against COVID-19. The study, published in the journal Nature Structural & Molecular Biology, noted that the 'nanobodies' can prevent infection with the novel coronavirus SARS-CoV-2 by blocking its interaction with the protein ACE2, which it uses as a gateway to enter and infect cells. According to the scientists, including those from The Rosalind Franklin Institute in the UK, passive immunization, which involves giving a patient virus-neutralizing agent either from people previously infected with SARS-CoV-2 or purified antibodies can be a useful therapy for COVID-19. They said antibodies against the 2002-03 SARS pandemic virus could prevent infection of cells by blocking the binding of the virus' spike protein to ACE2. However, they said many of these antibodies do not have the same reaction with SARS-CoV-2. In the current study, they tested the ability of antibodies derived from the South American mammal's llamas in neutralizing SARS-CoV-2.

The researchers explained that human antibodies, like those of most mammals, have two chains -- heavy and light -- but camelids, such as llamas, also possess an additional single heavy chain antibody variant, known as a nanobody. Nanobodies are small, stable, and easily produced and thus often serve as alternatives to conventional antibodies for diagnostics and imaging, the scientists said. According to the researchers, these small antibodies are currently being developed against SARS-CoV-2 as research tools and potential therapeutics.

The scientists, including James Naismith and Raymond Owens from The Rosalind Franklin Institute, identified and characterized two closely related nanobodies that could block the attachment of the SARS-CoV-2 spike to ACE2 in cell culture. They said these nanobodies, named H11-H4 and H11-D4, target a region of the protein "immediately adjacent to and slightly overlapping with the ACE2 binding region." According to the study, both the nanobodies were shown to neutralize live SARS-CoV-2, with H11-H4 showing particularly high potency and additive neutralization with a human antibody. The scientists said the nanobodies either alone, or in combination with other antibodies, may find application for passive immunization of patients with severe COVID-19. As camelid-derived antibodies are highly conserved with their human counterparts, they said these are likely to generate only low immune responses against humans. However, the scientists said these nanobodies can be humanized using known techniques.


TRENDING

OPINION / BLOG / INTERVIEW

Canada’s COVID-19 pitfalls highlight need for integrated health information system

In the globalized world of today where outbreaks can spread far and wide within a matter of days, a global-level integrated health information system is ideal but Canadas provincial barriers show that the country lags much behind in deployi...

Pandemic must be impetus, not obstacle, for clean water access

To make matters worse, there are suspicions that the inadequacy of wastewater treatment methods in California, the rest of the USA, and indeed around the world may help to propagate the disease even more widely. ...

3D printing and the future of manufacturing post COVID-19

The on-demand, customizable, and localized manufacturing of product components facilitated by 3D printing has the potential to redefine manufacturing but there are certain technical, mechanical, and legal limitations that, unless ...

How UK’s 'best prepared' healthcare system failed to gauge COVID-19

The UK is proud of their public health system and its unlike any other country as around 90 percent of British public supports the founding principles of National Health Service. But without accurate data being available to stakeholders in ...

Videos

Latest News

Sebi bans 27 entities from mkts in matter of front running by Reliance Securities dealers, connected entities

Regulator Sebi has barred a number of individuals and entities from the capital market after it unearthed a major case of front running by some dealers of Reliance Securities Ltd and their connected entities by using their prior access to s...

James Anderson praises team environment as Ben Stokes leaves series for family issue

England pacer James Anderson has lauded the team environment after all-rounder Ben Stokes left the ongoing series with Pakistan midway to spend time with his family in New Zealand. On Sunday, England and Wales Cricket Board ECB announced th...

New Delhi, Aug 10 (PTI) These are the top stories of the northern region at 9 pm.

These are the top stories of the northern region at 9 pm. . DEL70 2NDLD RAHUL-SACHIN PILOT Rebel Cong leader Sachin Pilot meets Rahul Gandhi, Priyanka Gandhi Vadra amid hints of breakthrough New Delhi Ahead of the crucial Rajasthan as...

GRP arrests wanted criminal in Muzaffarnagar

The Government Railway Police GRP on Monday arrested a man, wanted in several cases, from the railway station here, an official said. Suraj was planning to commit robbery at the station. A pistol and some cartridges have been seized, the o...

Give Feedback